What is NDC 60215-411?

60215-411 is the product NDC for Fludeoxyglucose F18, Fludeoxyglucose f-18 300 mCi/mL injection, listed with the FDA by The University of Texas MD Anderson Cancer Center. It has 1 package NDC, shown above in 10- and 11-digit form.

The University of Texas MD Anderson Cancer Center, NDC labeler code 60215. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Fludeoxyglucose F18?

8 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Fludeoxyglucose F18 NDC 60215-411 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)60215-411Labeler and product segments. Claims need a package NDC.

Product NDC at billing width60215-0411Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
60215-411-30	6021504113060215041130	27 mL in 1 VIAL, GLASS (60215-411-30)Marketed from Dec 6, 2011

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Fludeoxyglucose F18Suffix: F18
Generic name (nonproprietary): fludeoxyglucose f18
Active ingredients: Fludeoxyglucose f-18 — 300 mCi/mL
Dosage form: Injection
Route: Intravenous
Labeler: The University of Texas MD Anderson Cancer CenterNDC labeler code 60215
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 203246
Marketing start: Dec 6, 2011
Listing expires: Dec 31, 2026
Other FDA classes: Radiopharmaceutical Activity (Mechanism)
Identifiers: Product ID 60215-411_4041af0a-011f-ddc6-e063-6394a90af478SPL ID 4041af0a-011f-ddc6-e063-6394a90af478SPL set ID 43954e40-bb95-4275-92ab-96211b7de907UNII 0Z5B2CJX4D
Pharmacologic class: Radioactive Diagnostic Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N460215041130 followed by a unit qualifier and the quantity

Package 60215-0411-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 3, 2025.

Indications (excerpt from the label)

1. INDICATIONS AND USAGE Fludeoxyglucose F18 Injection is indicated for positron emission tomography (PET) imaging in the following settings: Fludeoxyglucose F18 Injection is indicated for positron emission tomography (PET) imaging in the following settings: Oncology: For assessment of abnormal glucose metabolism to assist in the evaluation of malignancy in patients with known or suspected abnormalities found by other testing modalities, or in patients with an existing diagnosis of cancer. Cardiology: For the identification of left ventricular myocardium with residual glucose metabolism and reversible loss of systolic function in patients with coronary artery disease and left ventricular dy…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 60215-411

What is NDC 60215-411?: 60215-411 is the product NDC for Fludeoxyglucose F18, Fludeoxyglucose f-18 300 mCi/mL injection, listed with the FDA by The University of Texas MD Anderson Cancer Center. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Fludeoxyglucose F18.
What is the active ingredient?: Fludeoxyglucose f-18.
Who is the labeler?: The University of Texas MD Anderson Cancer Center, NDC labeler code 60215. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Fludeoxyglucose F18?: 8 other product NDCs are listed under this name. See all Fludeoxyglucose F18 NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Fludeoxyglucose F18 NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Fludeoxyglucose F18	Fludeoxyglucose f-18 100 mCi/mL	InjectionIntravenous	Kreitchman PET Center	62072-008	62072-0008-30
Fludeoxyglucose F18	Fludeoxyglucose f-18 300 mCi/mL	InjectionIntravenous	The Regents of the University of Michigan	76326-001	76326-0001-20
Fludeoxyglucose F18fludeoxyglucose f-18	Fludeoxyglucose f-18 300 mCi/mL	Injection, SolutionIntravenous	Biomedical Research Foundation of Northwest Louisiana	24562-003	24562-0003-30
Fludeoxyglucose F18	Fludeoxyglucose f-18 300 mCi/mL	InjectionIntravenous	MIPS Cyclotron & Radiochemistry Facility	69587-001	69587-0001-01
Fludeoxyglucose F18	Fludeoxyglucose f-18 .3 Ci/mL	Injection, SolutionIntravenous	The Methodist Hospital Research Institute	69864-001	69864-0001-30
Fludeoxyglucose F18	Fludeoxyglucose f-18 300 mCi/mL	InjectionIntravenous	3D Imaging Drug Design and Development LLC	76451-118	76451-0118-1076451-0118-30
Fludeoxyglucose F18	Fludeoxyglucose f-18 300 mCi/mL	InjectionIntravenous	UCSF Radiopharmaceutical Facility	24275-0185	24275-0185-01
Fludeoxyglucose F18	Fludeoxyglucose f-18 400 mCi/mL	InjectionIntravenous	THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH	13267-234	13267-0234-45